

Author: Mathé-Allainmat M. Andrieux J. Langlois M.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.7, Iss.12, 1997-12, pp. : 1447-1458
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. :




Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. :